Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tynisha S. Rafael
Observed name:
Tynisha Rafael
Institutions:
The Netherlands Cancer Institute,
Amsterdam University Medical Centers,
Cancer Center Amsterdam,
Amsterdam institute for Immunology and Infectious Diseases,
Amsterdam UMC Location Vrije Universiteit Amsterdam
Observed institutions:
Leiden University Medical Center,
The Netherlands Cancer Institute,
Amsterdam University Medical Centers,
Cancer Center Amsterdam,
Amsterdam institute for Immunology and Infectious Diseases,
Amsterdam UMC Location Vrije Universiteit Amsterdam
show all 6
ORCID:
0009-0005-6038-2770
Observed ORCID:
0009-0005-6038-2770
OpenAlex ID:
A5014028031
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial
2023
·
Hielke M. de Vries
, Tynisha S. Rafael
, et al.
·
Journal of Clinical Oncology
·
85
Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
2022
·
Tynisha S. Rafael
, Jossie Rotman
, et al.
·
Journal of Clinical Medicine
·
29
PDF
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE
2024
·
Supriya Chopra
, Tjalling Bosse
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
16
PDF
Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor
2021
·
Tynisha S. Rafael
, Hielke M. de Vries
, et al.
·
Frontiers in Immunology
·
12
PDF
Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer
2022
·
Hielke M. de Vries
, Sarah R. Ottenhof
, et al.
·
European Urology Open Science
·
4
PDF
2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)
2022
·
Supriya Chopra
, Ekaterina S Jordanova
, et al.
·
International Journal of Gynecological Cancer
·
4
PDF
Multicenter Evaluation of Morbidity and Predictors of Response to Imiquimod Treatment for Penile Intraepithelial Neoplasia
2024
·
Ofir Avitan
, Laura Elst
, et al.
·
European Urology Open Science
·
2
Penile intraepithelial neoplasia incidence, clinical classification, microenvironment and implications for imiquimod treatment
2024
·
Ofir Avitan
, Tynisha Rafael
, et al.
·
British Journal of Urology
·
2
Preexisting Immunity and hrHPV Status Determine Immunotherapy Response in Advanced Penile Cancer: Biomarkers and Overall Survival in the PERICLES Trial
2026
·
Tynisha S. Rafael
, Alberto Gil-Jimenez
, et al.
·
Cancer Immunology Research
Abstract 2488: The penile cancer tumor microenvironment and immunotherapy response: Results from the PERICLES trial
2024
·
Tynisha S. Rafael
, Alberto Gil-Jimenez
, et al.
·
Cancer Research
SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I
2023
·
Supriya Chopra
, Nanda Horeweg
, et al.
·
International Journal of Gynecological Cancer
PDF
Show more works
View as search
Works count:
11
Citation count:
154
H-index:
4
I10-index:
4
Year
Topic
Type